Back

Comparative characteristics of patients with and without transthyretin amyloid cardiomyopathy in the TTRACK study population

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Pathophysioloy and prognosis on heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Francesco Cappelli

Careggi University Hospital (AOUC), Florence (Italy)

3 More presentations in this session

Presentation thumbnail
Machine learning-based phenogrouping for clinical outcomes and treatment response in patients with chronic heart failure
Doctor M. Nakao (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Effect of paracetamol on cardiovascular outcomes in patients with heart failure: a multi-center cohort study
Doctor Q. Ren (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
The neutrophil to lymphocyte ratio (NRL) as a predictor of nutritional status in patients with heart failure with reduced ejection fraction
Miss M. Cierzniak (Poznan, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysioloy and prognosis on heart failure

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Comparative characteristics of patients with cardiac amyloidosis with and without monoclonal gammopathy in the TTRACK study population
thumbnail
Congress Presentation
Clinical presentation and treatment landscape of patients with transthyretin amyloidosis with cardiomyopathy: a real-world study in five European countries and Japan
thumbnail
Congress Presentation
Cardiac resynchronization therapy, remodeling and outcome in patients with amyloid transthyretin cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources